As the 'First City of Digital Economy,' Hangzhou leverages its advantages in digital and medical resources to support ...
The Trump administration is considering putting “severe restrictions” on the increasing flow of investigational drugs from ...
Stocktwits on MSN
Big Pharma Eyes China: J&J And Roche Reportedly In Talks For Henlius’ Experimental Cancer Drug
Johnson & Johnson and Roche are reportedly in discussions with Shanghai Henlius Biotech, a unit of Fosun Pharma, over the ...
BMS is exiting the first U.S.-China pharmaceutical joint venture. Kalexo Bio and Ollin Biosciences have launched with big ...
U.S. pharma raises alarm over Trump’s proposed measures against Chinese drugs; China clarifies the type of employees to be ...
Pfizer Inc. faces significant uncertainty due to declining COVID-19 sales and potential policy changes. Learn more about PFE ...
Stocktwits on MSN
Nvidia, Pfizer, New Fortress Energy, Tesla, Alphabet: What Sparked Heavy After-Hours Trading In These 5 Stocks?
U.S. stocks experienced a modest pullback from their record highs as a strong August retail sales report tempered hopes of a ...
This episode of Pharma Pulse covers reports of a White House executive order to restrict treatments discovered in China, new data showing robust immune responses from Pfizer and BioNTech’s COVID-19 ...
The Trump administration is weighing the imposition of severe restrictions on medicines from China that, if enacted, could ...
A draft executive order obtained by The New York Times purports to clamp down on the pharmaceutical industry's ability to buy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback